Pharmacelera - About the company
Pharmacelera is a series A company based in Barcelona (Spain), founded in 2015 by Enric Herrero and Enric Gibert Codina. It operates as a Hardware and software solutions for computer-aided drug design. Pharmacelera has raised $7.1M in funding from HERAN Partners. The company has 184 active competitors, including 43 funded and 19 that have exited. Its top competitors include companies like Certara, Cartography Biosciences and Astex Pharmaceuticals.
Company Details
Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.
- Website
- pharmacelera.com
- Email ID
- *****@pharmacelera.com
Key Metrics
Founded Year
2015
Location
Barcelona, Spain
Stage
Series A
Total Funding
$7.1M in 6 rounds
Latest Funding Round
Investors
Ranked
4th among 184 active competitors
Employee Count
28 as on Jul 31, 2026
Sign up to download Pharmacelera's company profile
Pharmacelera's funding and investors
Pharmacelera has raised a total funding of $7.1M over 6 rounds. Its first funding round was on Jun 01, 2018. Its latest funding round was a Series A round on Feb 18, 2026 for $*****. 4 investors participated in its latest round. Pharmacelera has 8 institutional investors.
Here is the list of recent funding rounds of Pharmacelera:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 18, 2026 | 9202354 | Series A | 9370115 | 9639127 | 3399082 | 3361447 |
Aug 31, 2022 | 6989207 | Grant (prize money) | 5685133 | 8536781 | 6034947 | |
Sep 01, 2020 | 9484838 | Grant (prize money) | 8663246 | 6524924 | 4416569 |
View details of Pharmacelera's funding rounds and investors
Pharmacelera's founders and board of directors
Founder? Claim ProfileThe founders of Pharmacelera are Enric Herrero and Enric Gibert Codina. Enric Gibert Codina is the CEO of Pharmacelera.
Here are the details of Pharmacelera's key team members:
- Enric Herrero: Co-Founder & CTO of Pharmacelera. Contact Info: 1 email address
- Enric Gibert Codina: Co-Founder & CEO of Pharmacelera.
View details of Pharmacelera's Founder profiles and Board Members
Pharmacelera's employee count trend
Pharmacelera has 28 employees as of Jul 26. Here is Pharmacelera's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Pharmacelera's Competitors and alternates
Top competitors of Pharmacelera include Certara, Cartography Biosciences and Astex Pharmaceuticals. Here is the list of Top 10 competitors of Pharmacelera, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Certara 2008, Princeton (United States), Public | Provider of a platform for in silico drug discovery and consulting services | - | 65/100 | |
2nd | Cartography Biosciences 2020, Foster City (United States), Series B | Provider of a platform to discover immunotherapeutics | $124M | 63/100 | |
3rd | Astex Pharmaceuticals 1991, Pleasanton (United States), Acquired | Oncology and CNS drug discovery and development using cutting-edge technology | $3M | 60/100 | |
4th | Pharmacelera 2015, Barcelona (Spain), Series A | Hardware and software solutions for computer-aided drug design | $7.1M | 59/100 | |
5th | TOLREMO therapeutics 2017, Zurich (Switzerland), Series A | Developing anti-cancer small molecules targeting novel drug resistance pathways | $55.8M | 59/100 | |
6th | Oxford Drug Design 2001, Oxford (United Kingdom), Series A | Provider of computer-aided design of antibiotics for MDR infections | $12.4M | 59/100 | |
7th | Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 58/100 | |
8th | Genialis 2015, Boston (United States), Series A | Developer of end-to-end bioinformatics software solutions | $16M | 56/100 | |
9th | CytoReason 2016, Haifa (Israel), Series C | Discovering immune system based drugs by biological data analytics | $130M | 55/100 | |
10th | Probius 2016, Fremont (United States), Seed | Digital biochemical analysis tool for healthcare researchers | $2.44M | 53/100 |
Looking for more details on Pharmacelera's competitors? Click here to see the top ones
Pharmacelera's Investments and acquisitions
Pharmacelera has made no investments or acquisitions yet.
Reports related to Pharmacelera
Here is the latest report on Pharmacelera's sector:
News related to Pharmacelera
Media has covered Pharmacelera for a total of 2 events in the last 1 year.
•
Pharmacelera closes a €6M round led by Heran. Clave Capital, Inveready and Bio&Tech Smart participateWebcapitalriesgo•Mar 12, 2026•HERAN Partners, Pharmacelera
•
Pharmacelera Raises €6M to Expand in U.S.PR Newswire•Feb 18, 2026•HERAN Partners, Pharmacelera, Clave Capital, Bio&Tech Smart Capital and 2 others
•
Pharmacelera Chooses Science Exchange As Its Primary Online Channel To Offer Proprietary Computational Chemistry ServicesBusiness Wire•May 23, 2018•Pharmacelera, Science Exchange
Are you a Founder ?
FAQs about Pharmacelera
Explore our recently published companies
- Haile Construction - United States based, 2013 founded, Unfunded company
- ING-GRAD - Croatia based, 1985 founded, Unfunded company
- Metro - St. Gallen based, 2002 founded, Public company
- Studio Thirty Seven - Pecs based, Unfunded company
- Soy Best - Nebraska City based, 1958 founded, Unfunded company
- Post High School - Post based, Funding Raised company